These value are improved when compared against those reported by others for traditional biomarkers of AKI including NGAL, KIM-1, and IL-18 [11, 21] and comparable to those reported for [TIMP-2 * IGFBP-7] [11, 16, 17]. This evidence concerns the gene LCN2 and acute kidney injury.